Related references
Note: Only part of the references are listed.The Emerging Hallmarks of Cancer Metabolism
Natalya N. Pavlova et al.
CELL METABOLISM (2016)
Mass spectrometry imaging of amino neurotransmitters: a comparison of derivatization methods and application in mouse brain tissue
Clara Esteve et al.
METABOLOMICS (2016)
The stress kinase GCN2 does not mediate suppression of antitumor T cell responses by tryptophan catabolism in experimental melanomas
Jana K. Sonner et al.
ONCOIMMUNOLOGY (2016)
Tryptophan PET Imaging of the Kynurenine Pathway in Patient-Derived Xenograft Models of Glioblastoma
Anthony R. Guastella et al.
MOLECULAR IMAGING (2016)
Novel technologies and emerging biomarkers for personalized cancer immunotherapy
Jianda Yuan et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
The potential of targeting indoleamine 2,3-dioxygenase for cancer treatment
Johanna M. Gostner et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
Combination cancer immunotherapy and new immunomodulatory targets
Kathleen M. Mahoney et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
NIMG-38MULTIMODAL IMAGING OF SPATIAL PATTERNS OF POST-TREATMENT GLIOBLASTOMA PROGRESSION
Edit Bosnyak et al.
NEURO-ONCOLOGY (2015)
T cell metabolic fitness in antitumor immunity
Peter J. Siska et al.
TRENDS IN IMMUNOLOGY (2015)
Accumulation of an Endogenous Tryptophan-Derived Metabolite in Colorectal and Breast Cancers
Paolo Puccetti et al.
PLOS ONE (2015)
On-Tissue Localization of Ceramides and Other Sphingolipids by MALDI Mass Spectrometry Imaging
E. Ellen Jones et al.
ANALYTICAL CHEMISTRY (2014)
Label-free MS imaging from drug discovery to preclinical development
Guillaume Hochart et al.
BIOANALYSIS (2014)
Does the immune system naturally protect against cancer?
Alexandre Corthay
FRONTIERS IN IMMUNOLOGY (2014)
Trial watch: IDO inhibitors in cancer therapy
Erika Vacchelli et al.
ONCOIMMUNOLOGY (2014)
Matrix-Assisted Laser Desorption Ionization Imaging Mass Spectrometry: In Situ Molecular Mapping
Peggi M. Angel et al.
BIOCHEMISTRY (2013)
Identification of New Apolipoprotein-CIII Glycoforms with Ultrahigh Resolution MALDI-FTICR Mass Spectrometry of Human Sera
Simone Nicolardi et al.
JOURNAL OF PROTEOME RESEARCH (2013)
Comprehensive Identification of Proteins from MALDI Imaging
Stefan K. Maier et al.
MOLECULAR & CELLULAR PROTEOMICS (2013)
Metabolites of tryptophan catabolism are elevated in sera of patients with myelodysplastic syndromes and inhibit hematopoietic progenitor amplification
Celine Berthon et al.
LEUKEMIA RESEARCH (2013)
Indoleamine 2,3 dioxygenase and metabolic control of immune responses
David H. Munn et al.
TRENDS IN IMMUNOLOGY (2013)
Quantitative mass spectrometry imaging of propranolol and olanzapine using tissue extinction calculation as normalization factor
Gregory Hamm et al.
JOURNAL OF PROTEOMICS (2012)
IDO inhibits a tryptophan sufficiency signal that stimulates mTOR A novel IDO effector pathway targeted by D-1-methyl-tryptophan
Richard Metz et al.
ONCOIMMUNOLOGY (2012)
Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity
Xiangdong Liu et al.
BLOOD (2010)
Serum concentration of L-kynurenine predicts the clinical outcome of patients with diffuse large B-cell lymphoma treated with R-CHOP
Takeshi Yoshikawa et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Classification of HER2 Receptor Status in Breast Cancer Tissues by MALDI Imaging Mass Spectrometry
Sandra Rauser et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Indoleamine 2,3-dioxygenase activity of acute myeloid leukemia cells can be measured from patients' sera by HPLC and is inducible by IFN-γ
Selim Corm et al.
LEUKEMIA RESEARCH (2009)
Indoleamine 2,3-dioxygenase is highly expressed in human adult T-cell leukemia/lymphoma and chemotherapy changes tryptophan catabolism in serum and reduced activity
Masato Hoshi et al.
LEUKEMIA RESEARCH (2009)
Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees?
Stefan Loeb et al.
NATURE REVIEWS CANCER (2009)
Imaging mass spectrometry
Liam A. McDonnell et al.
MASS SPECTROMETRY REVIEWS (2007)
Inhibitory effect of tumor cell-derived lactic acid on human T cells
Karin Fischer et al.
BLOOD (2007)
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer
K. Ino et al.
BRITISH JOURNAL OF CANCER (2006)
Tumor-derived lactic acid modulates dendritic cell activation and antigen expression
E Gottfried et al.
BLOOD (2006)
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
C Uyttenhove et al.
NATURE MEDICINE (2003)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
Share Paper
